Starpharma Holdings Limited (SPL.AX)
AUD 0.09
(0.0%)
AUD 0.09
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 36.81 Million AUD | -29.32% |
| 2023 | 52.08 Million AUD | -21.29% |
| 2022 | 66.17 Million AUD | -9.64% |
| 2021 | 73.23 Million AUD | 87.41% |
| 2020 | 39.07 Million AUD | -20.02% |
| 2019 | 48.85 Million AUD | -16.5% |
| 2018 | 58.51 Million AUD | -12.13% |
| 2017 | 66.59 Million AUD | 12.79% |
| 2016 | 59.03 Million AUD | 33.02% |
| 2015 | 44.38 Million AUD | 20.4% |
| 2014 | 36.86 Million AUD | -24.07% |
| 2013 | 48.55 Million AUD | -10.54% |
| 2012 | 54.26 Million AUD | 82.06% |
| 2011 | 29.8 Million AUD | -20.66% |
| 2010 | 37.56 Million AUD | 30.23% |
| 2009 | 28.84 Million AUD | 17.01% |
| 2008 | 24.65 Million AUD | -18.97% |
| 2007 | 30.42 Million AUD | 21.63% |
| 2006 | 25.01 Million AUD | 100.11% |
| 2005 | 12.49 Million AUD | -32.4% |
| 2004 | 18.49 Million AUD | 72.56% |
| 2003 | 10.71 Million AUD | -43.18% |
| 2002 | 18.85 Million AUD | -27.53% |
| 2001 | 26.02 Million AUD | -10.42% |
| 2000 | 29.05 Million AUD | 0.0% |
| 1999 | - AUD | 0.0% |
| 1998 | - AUD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q4 | 36.81 Million AUD | 0.0% |
| 2024 Q2 | 43.93 Million AUD | 0.0% |
| 2024 FY | 36.81 Million AUD | -29.32% |
| 2023 Q4 | 52.08 Million AUD | 0.0% |
| 2023 Q2 | 57.64 Million AUD | 0.0% |
| 2023 FY | 52.08 Million AUD | -21.29% |
| 2022 Q4 | 66.17 Million AUD | 0.0% |
| 2022 Q2 | 67.32 Million AUD | 0.0% |
| 2022 FY | 66.17 Million AUD | -9.64% |
| 2021 Q4 | 73.23 Million AUD | 0.0% |
| 2021 FY | 73.23 Million AUD | 87.41% |
| 2021 Q2 | 77.98 Million AUD | 0.0% |
| 2020 FY | 39.07 Million AUD | -20.02% |
| 2020 Q2 | 46.66 Million AUD | 0.0% |
| 2020 Q4 | 39.07 Million AUD | 0.0% |
| 2019 Q2 | 52.19 Million AUD | 0.0% |
| 2019 Q4 | 48.85 Million AUD | 0.0% |
| 2019 FY | 48.85 Million AUD | -16.5% |
| 2018 Q2 | 60.84 Million AUD | 0.0% |
| 2018 Q4 | 58.51 Million AUD | 0.0% |
| 2018 FY | 58.51 Million AUD | -12.13% |
| 2017 FY | 66.59 Million AUD | 12.79% |
| 2017 Q4 | 66.59 Million AUD | 0.0% |
| 2017 Q2 | 46.92 Million AUD | 0.0% |
| 2016 Q4 | 59.03 Million AUD | 0.0% |
| 2016 Q2 | 66.37 Million AUD | 0.0% |
| 2016 FY | 59.03 Million AUD | 33.02% |
| 2015 FY | 44.38 Million AUD | 20.4% |
| 2015 Q4 | 44.38 Million AUD | 0.0% |
| 2015 Q2 | 50.72 Million AUD | 0.0% |
| 2014 FY | 36.86 Million AUD | -24.07% |
| 2014 Q2 | 44.62 Million AUD | 0.0% |
| 2014 Q4 | 36.86 Million AUD | 0.0% |
| 2013 Q2 | 51.03 Million AUD | 0.0% |
| 2013 Q4 | 48.55 Million AUD | 0.0% |
| 2013 FY | 48.55 Million AUD | -10.54% |
| 2013 Q1 | 51.03 Million AUD | -5.95% |
| 2013 Q3 | 48.55 Million AUD | -4.87% |
| 2012 FY | 54.26 Million AUD | 82.06% |
| 2012 Q4 | 54.26 Million AUD | 0.0% |
| 2011 Q4 | 29.8 Million AUD | 0.0% |
| 2011 FY | 29.8 Million AUD | -20.66% |
| 2010 FY | 37.56 Million AUD | 30.23% |
| 2010 Q4 | 37.56 Million AUD | 0.0% |
| 2009 FY | 28.84 Million AUD | 17.01% |
| 2009 Q4 | 28.84 Million AUD | 0.0% |
| 2008 FY | 24.65 Million AUD | -18.97% |
| 2008 Q4 | 24.65 Million AUD | 0.0% |
| 2007 Q4 | 30.42 Million AUD | 0.0% |
| 2007 FY | 30.42 Million AUD | 21.63% |
| 2006 FY | 25.01 Million AUD | 100.11% |
| 2006 Q4 | 25.01 Million AUD | 0.0% |
| 2005 FY | 12.49 Million AUD | -32.4% |
| 2005 Q4 | 12.49 Million AUD | 0.0% |
| 2004 Q4 | 18.49 Million AUD | 0.0% |
| 2004 FY | 18.49 Million AUD | 72.56% |
| 2003 Q4 | 10.71 Million AUD | 0.0% |
| 2003 FY | 10.71 Million AUD | -43.18% |
| 2002 FY | 18.85 Million AUD | -27.53% |
| 2002 Q4 | 18.85 Million AUD | 0.0% |
| 2001 Q4 | 26.02 Million AUD | 0.0% |
| 2001 FY | 26.02 Million AUD | -10.42% |
| 2000 FY | 29.05 Million AUD | 0.0% |
| 1999 FY | - AUD | 0.0% |
| 1998 FY | - AUD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| AdAlta Limited | 5.57 Million AUD | -560.578% |
| Acrux Limited | 8.96 Million AUD | -310.733% |
| Actinogen Medical Limited | 21.31 Million AUD | -72.739% |
| AnteoTech Limited | 9.38 Million AUD | -292.424% |
| Argenica Therapeutics Limited | 16.37 Million AUD | -124.783% |
| Arovella Therapeutics Limited | 13.28 Million AUD | -177.116% |
| Anatara Lifesciences Ltd | 1.67 Million AUD | -2102.556% |
| Alterity Therapeutics Limited | 19.22 Million AUD | -91.503% |
| Amplia Therapeutics Limited | 14.84 Million AUD | -147.987% |
| Avecho Biotechnology Limited | 7.31 Million AUD | -402.971% |
| Bio-Gene Technology Limited | 3.15 Million AUD | -1065.151% |
| Biome Australia Limited | 8.27 Million AUD | -344.786% |
| Biotron Limited | 493.47 Thousand AUD | -7360.14% |
| Botanix Pharmaceuticals Limited | 112.46 Million AUD | 67.266% |
| BTC Health Limited | 5.14 Million AUD | -615.001% |
| Chimeric Therapeutics Limited | 15.27 Million AUD | -141.037% |
| CSL Limited | 56.93 Billion AUD | 99.935% |
| Clarity Pharmaceuticals Ltd | 154.62 Million AUD | 76.192% |
| Clinuvel Pharmaceuticals Limited | 231.12 Million AUD | 84.072% |
| Cynata Therapeutics Limited | 8.38 Million AUD | -338.874% |
| Dimerix Limited | 32.07 Million AUD | -14.762% |
| EZZ Life Science Holdings Limited | 25.55 Million AUD | -44.075% |
| Hexima Limited | 2.26 Million AUD | -1522.474% |
| Island Pharmaceuticals Limited | 2.56 Million AUD | -1335.54% |
| Immuron Limited | 15.54 Million AUD | -136.746% |
| Immutep Limited | 147.44 Million AUD | 75.033% |
| Imugene Limited | 151.39 Million AUD | 75.684% |
| Invex Therapeutics Ltd | 6.12 Million AUD | -501.531% |
| Memphasys Limited | 12.43 Million AUD | -196.167% |
| Nanollose Limited | 241.95 Thousand AUD | -15115.478% |
| Neuren Pharmaceuticals Limited | 247.97 Million AUD | 85.154% |
| Noxopharm Limited | 6.78 Million AUD | -442.679% |
| NeuroScientific Biopharmaceuticals Limited | 5.43 Million AUD | -577.242% |
| Nyrada Inc. | 5.9 Million AUD | -523.199% |
| Orthocell Limited | 26.61 Million AUD | -38.319% |
| PharmAust Limited | 11.12 Million AUD | -230.917% |
| Patrys Limited | 4.16 Million AUD | -784.616% |
| Paradigm Biopharmaceuticals Limited | 27.39 Million AUD | -34.405% |
| Proteomics International Laboratories Limited | 10.87 Million AUD | -238.516% |
| Prescient Therapeutics Limited | 20.39 Million AUD | -80.524% |
| PYC Therapeutics Limited | 91.23 Million AUD | 59.651% |
| Race Oncology Limited | 20.22 Million AUD | -81.99% |
| Radiopharm Theranostics Limited | 72.03 Million AUD | 48.895% |
| Recce Pharmaceuticals Ltd | 6.36 Million AUD | -477.963% |
| Telix Pharmaceuticals Limited | 398.3 Million AUD | 90.757% |
| Tissue Repair Ltd | 19.38 Million AUD | -89.865% |
| Zelira Therapeutics Limited | 5.18 Million AUD | -610.226% |